Neurizon Therapeutics Limited (ASX:NUZ) Reports New Preclinical Data Supporting ALS Treatment
Neurizon Therapeutics (ASX:NUZ) announces positive preclinical results for NUZ-001, highlighting its potential as a transformative ALS therapy.
Neurizon Therapeutics Limited
Neurizon Therapeutics (ASX:NUZ) announces positive preclinical results for NUZ-001, highlighting its potential as a transformative ALS therapy.